Question 1

How many shares of BCRX does BAKER BROS. ADVISORS LP own?

Accepted Answer

BAKER BROS. ADVISORS LP previously held 0 shares of BCRX (BIOCRYST PHARMACEUTICALS INC) before exiting the position in 2026-Q1.

Question 2

What is BAKER BROS. ADVISORS LP's BCRX position worth?

Accepted Answer

BAKER BROS. ADVISORS LP's BCRX position was last reported at $0 in 2026-Q1 before the exit.

Question 3

Is BAKER BROS. ADVISORS LP buying or selling BCRX?

Accepted Answer

In 2026-Q1, BAKER BROS. ADVISORS LP exited their BCRX position entirely (-100.0% change in shares).

Question 4

When did BAKER BROS. ADVISORS LP first buy BCRX?

Accepted Answer

Based on available 13F filings, BAKER BROS. ADVISORS LP first reported a position in BCRX in 2024-Q3. They have held the position across 26 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$9.52	0
2025-Q4	New	2.8M	—	$22M	0.1%	$7.80	47
2024-Q4	Exited	0	-100.0%	$0	0.0%	$7.52	0
2024-Q3	Unchanged	75,778	0.0%	$575,913	0.0%	$7.60	0